Works Cited



Argov, Z., & Mastaglia, F. (1979). British Medical Journal. Drug-induced peripheral neuropathies. 1,663-666.

Arnold, A. and Williams, C. (1979, April). British Medical Journal. Drug-Induced Peripheral Neuropathies.

Backonja, M., Beydoun, A., Edwards, K.R., Schwarts, S.L., Fonseca, V., Hes, M., LaMoreaux, L., Garofalo, E. (1998). JAMA. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. 280 (21).

Bennett, G., & Flatters, S. (2006). Pain. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. 122(3), 245-257.

Benson, J. et al. (1979). British Medical Journal. Spinal-cord Compression in Myeloma. 1, 1541-1544.

Bianchi, R. et al. (2004). PNAS. Erythropoietin both protects from and reverses experimental diabetic neuropathy. 101 (3), 823-828.

Campbell, J. and Meyer, R. (2006). Neuron. Mechanisms of Neuropathic Pain. 52 (1), 77-92.

Critchley, E. British Medical Journal. (1979) Drug-induced diseases; Drug-induced neurological disease. 1, 862-865.

Eade, O. et al. (1975). British Medical Journal. Peripheral Neuropathy and Indomethacin. 2, 66-67.

Flatters, S., Xiao, W., & Bennett, G. (2006). Neurosci Lett. Acetyl-L-Carnitine Prevents and Reduces Paclitaxel-Induced Painful Peripheral Neuropathy. 397 (3), 219-223.

Fullerton, P. (1969, February). Section of Occupational Medicine. Toxic Chemicals and Peripheral Neuropathy. 62.

Hughes, R. et al. (1994, September). Journal of the Royal Society of Medicine. Effects of lymphoma on the peripheral nervous system. 87.

Leonard, G. et al. (2005). BMC Cancer. Survey of oxaliplatin-associated neurotoxity using an interview-based questionnaire. 5, 116.

Max, M.B., Culnane, M., Schafer, S.C., Gracely, R.H., Walther, D.J., Smoller, B., Dubner, R. (1987). American Academy of Neurology. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. (589).

Nudleman, K. (1998, February). WJM. Preventing Chemotherapy-induced Neuropathy. 168(2).

Ossipov, M. and Porreca, F. (2005). NeurRx. Challenges in the Development of Novel Treatment Strategies for Neuropathic Pain. 2, 650-661.

Ravits, J. (1998, April). WJM. Recent Advancements in the Treatment of Neuropathies. 168(4).

Roberts, A. (1970, January). British Medical Journal. Neurological Complications of Systemic Diseases. 1.

Siau, C. and Bennett, G. (2006). Anesth Analg. Dysregulation of Cellular Calcium Homeostasis in Chemotherapy-Evoked Painful Peripheral Neuropathy. 102(5), 1485-1490.

Simmons, Z., & Feldman, E. Diabetic Neuropathy. http://www.neuropathy.org/site/PageServer?pagename=Type_Diabetic
Accessed December 9th, 2007.

Thomas, P. (1970, February). British Medical Journal. Practical Neurology – Peripheral Neuropathy. 2.

Xiao, W. et al. (2007). Neuroscience. Chemotherapy-Evoked Painful Peripheral Neuropathy: Analgesic Effects of Gabapentin and Effects on Expression of the Alpha-2-Delta Type 1 Calcium Channel Subunit. 144(2), 714-720.

 

Sources Not Cited (simply used for better understanding of a topic or word):

http://www.neurology.org/cgi/content/abstract/56/12/1621

http://www.healthatoz.com/healthatoz/Atoz/common/standard/transform.jsp?requestURI=/healthatoz/Atoz/ency/plasmapheresis.jsp

http://www.mayoclinic.com/health/peripheral-neuropathy/DS00131

http://health.yahoo.com/other-other/immune-globulin-intravenous-igiv/healthwise--d01133a1.html

http://gateway.nlm.nih.gov/MeetingAbstracts/102202279.html

http://www.aafp.org/afp/20050601/2123.html